enGene Therapeutics Inc.

Biological Products, (No Diagnostic Substances) | SIC: 2836
Phone: (514) 332-4888
CIK: 0001980845
State of Inc.: Z4
Tickers:
  • Nasdaq:ENGN
  • Nasdaq:ENGNW

Form: UPLOAD

Filing Date: 25 Feb 2026
Report Date:
Accepted: 25 Feb 2026 06:30 a.m.
Accession Number: 0000000000-26-001921
Act: None
File Number: 333-293597
Film Number: None

Documents

Primary Document
Accepted: 25 Feb 2026 06:30 a.m.